APUS Competitors & Alternatives

Compare Apimeds Pharmaceuticals US, Inc. with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

APUS

Main Stock
$2.11
Tradestie Score
52
Market Cap
$21.50M

Top Competitors

48 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
AQST Aquestive Therapeutics, Inc. Common Stock
$4.78
$711.32M - 40 Compare
ESPR Esperion Therapeutics, Inc.
$3.18
$584.71M - 53 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$57.08
$543.32M 152.3 43 Compare
EOLS Evolus, Inc. Common Stock
$7.84
$397.82M - 35 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$4.08
$237.15M 5.2 53 Compare
UFG Uni-Fuels Holdings Limited Class A Ordinary Shares
$0.57
$163.37M - 41 Compare
LIMN Liminatus Pharma, Inc. Class A Common Stock
$3.47
$46.82M - 32 Compare
GELS Gelteq Limited Ordinary Shares
$0.70
$12.94M - 35 Compare
OSRH OSR Holdings, Inc. Common Stock
$0.12
$12.30M - 42 Compare
PLRZ Polyrizon Ltd. Ordinary Shares
$11.03
$6.53M - 42 Compare

Data updated: Sep 13, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

48 stocks in this industry